米非司酮（RU-486）作为附表 IV 受控药物-对妇女保健误导性药物政策的影响。
Mifepristone (RU-486) as a Schedule IV Controlled Drug-Implications for a Misleading Drug Policy on Women's Health Care.
机构信息
Department of Social Work, University of North Dakota, Grand Forks, ND 58202, USA.
College of Law, National Chung-Cheng University, Chia-Yi 62102, Taiwan.
出版信息
Int J Environ Res Public Health. 2022 Jul 8;19(14):8363. doi: 10.3390/ijerph19148363.
BACKGROUND
Mifepristone (RU-486) has been approved for abortion in Taiwan since 2000. Mifepristone was the first non-addictive medicine to be classified as a schedule IV controlled drug. As a case of the "misuse" of "misuse of drugs laws," the policy and consequences of mifepristone-assisted abortion for pregnant women could be compared with those of illicit drug use for drug addicts.
METHODS
The rule-making process of mifepristone regulation was analyzed from various aspects of legitimacy, social stigma, women's human rights, and access to health care.
RESULTS AND DISCUSSION
The restriction policy on mifepristone regulation in Taiwan has raised concerns over the legitimacy of listing a non-addictive substance as a controlled drug, which may produce stigma and negatively affect women's reproductive and privacy rights. Such a restriction policy and social stigma may lead to the unwillingness of pregnant women to utilize safe abortion services. Under the threat of the COVID-19 pandemic, the US FDA's action on mifepristone prescription and dispensing reminds us it is time to consider a change of policy.
CONCLUSIONS
Listing mifepristone as a controlled drug could impede the acceptability and accessibility of safe mifepristone use and violates women's right to health care.
背景
米非司酮（RU-486）自 2000 年起在台湾获准用于堕胎。米非司酮是第一种被归类为第四附表管制药物的非成瘾性药物。作为“滥用毒品法”的“滥用”案例，米非司酮辅助堕胎的政策和后果可以与吸毒者非法使用毒品进行比较。
方法
从合法性、社会耻辱感、妇女人权和获得医疗保健等方面分析了米非司酮监管的制定过程。
结果与讨论
台湾对米非司酮管制的限制政策引起了人们对将非成瘾物质列为管制药物的合法性的关注，这可能会产生耻辱感，并对妇女的生殖和隐私权产生负面影响。这种限制政策和社会耻辱感可能导致孕妇不愿意使用安全的堕胎服务。在 COVID-19 大流行的威胁下，美国 FDA 对米非司酮处方和配药的行动提醒我们，是时候考虑改变政策了。
结论
将米非司酮列为管制药物可能会阻碍安全使用米非司酮的可接受性和可及性，并侵犯妇女的医疗保健权利。
Zotero 插件